APA

Vokes E. E., Drinkard L. C., Samuels B. L., Hoffman P. C., Watson S., Bitran J. D., Haraf D. J., Ferguson M. F. & Golomb H. M. (19941128). A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. : Seminars in oncology.

Chicago

Vokes E E, Drinkard L C, Samuels B L, Hoffman P C, Watson S, Bitran J D, Haraf D J, Ferguson M F and Golomb H M. 19941128. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. : Seminars in oncology.

Harvard

Vokes E. E., Drinkard L. C., Samuels B. L., Hoffman P. C., Watson S., Bitran J. D., Haraf D. J., Ferguson M. F. and Golomb H. M. (19941128). A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. : Seminars in oncology.

MLA

Vokes E E, Drinkard L C, Samuels B L, Hoffman P C, Watson S, Bitran J D, Haraf D J, Ferguson M F and Golomb H M. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. : Seminars in oncology. 19941128.